Table 11. Adverse events associated with reinfusion of filtered and concentrated ascites.
| Adverse events (with redundancy) |
Patients | Sessions | Time point (sessions) | Severity (sessions) | ||
|---|---|---|---|---|---|---|
| During reinfusion | After reinfusion | Severe | Not severe | |||
| Fever | 30 (20.5%) | 44 (12.4%) | 41 | 3 | 0 | 44 |
| Chills | 8 (5.5%) | 8 (2.3%) | 7 | 1 | 0 | 8 |
| Shivering with chills | 1 (0.7%) | 1 (0.3%) | 1 | 0 | 0 | 1 |
| Nausea | 1 (0.7%) | 1 (0.3%) | 1 | 0 | 0 | 1 |
| Hypertension | 1 (0.7%) | 1 (0.3%) | 1 | 0 | 0 | 1 |
| Headache | 1 (0.7%) | 1 (0.3%) | 0 | 1 | 0 | 1 |
| Any adverse events | 33 (22.6%) | 47 (13.2%) | 51 | 5 | 0 | 56 |
A considerable number of fever/chills cases were observed, but none of them was severe.